XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020   30,874,000      
Beginning balance at Dec. 31, 2020 $ 214,603 $ 9,257 $ 422,589 $ (189,565) $ (27,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (186,019) [1]     (186,019)  
Foreign currency translation adjustment, net of tax (2,214)       (2,214)
Defined benefit pension plans, net of tax 3,160       3,160
Non-cash compensation 7,013   7,013    
Net settlement of vested stock awards (in shares)   340,000      
Net settlement of vested stock awards (240) $ 102 (342)    
Issuance of warrant, net 15,564   15,564    
Reverse Stock Split Adjustment (in shares)   (28,092,000)      
Effect of reverse stock split 0 $ (8,423) 8,423    
Ending balance (in shares) at Dec. 31, 2021   3,122,000      
Ending balance at Dec. 31, 2021 51,867 $ 936 453,247 (375,584) (26,732)
Ending balance (Accounting Standards Update 2020-06) at Dec. 31, 2021 (1,825)   (5,650) 3,825  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 70,079     70,079  
Foreign currency translation adjustment, net of tax (6,589)       (6,589)
Defined benefit pension plans, net of tax (5,675)       (5,675)
Non-cash compensation 247   247    
Net settlement of vested stock awards (in shares)   1,221,000      
Net settlement of vested stock awards $ 9,656 $ 367 9,289    
Ending balance (in shares) at Dec. 31, 2022 4,342,909 4,343,000      
Ending balance at Dec. 31, 2022 $ 117,760 $ 1,303 $ 457,133 $ (301,680) $ (38,996)
[1] Consolidated statements of cash flows include discontinued operations.
December 31,
20222021
Cash and cash equivalents from continuing operations$58,075 $55,193 
Cash and cash equivalents from discontinued operations— 10,122 
Total$58,075 $65,315